S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
AAPL   264.47 (+1.02%)
FB   193.19 (-0.66%)
MSFT   147.31 (+0.16%)
GOOGL   1,296.18 (-0.08%)
AMZN   1,753.11 (-1.40%)
CGC   18.50 (-3.90%)
NVDA   208.57 (-0.50%)
MU   46.30 (-1.28%)
BABA   182.48 (-2.40%)
GE   11.29 (-1.14%)
TSLA   346.11 (-1.09%)
T   39.16 (-0.03%)
AMD   37.52 (+2.21%)
F   8.81 (-2.54%)
ACB   3.55 (-0.56%)
PRI   128.60 (-1.04%)
NFLX   283.11 (-3.05%)
BAC   32.79 (-0.91%)
GILD   63.33 (-1.54%)
DIS   148.72 (+7.32%)
S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
AAPL   264.47 (+1.02%)
FB   193.19 (-0.66%)
MSFT   147.31 (+0.16%)
GOOGL   1,296.18 (-0.08%)
AMZN   1,753.11 (-1.40%)
CGC   18.50 (-3.90%)
NVDA   208.57 (-0.50%)
MU   46.30 (-1.28%)
BABA   182.48 (-2.40%)
GE   11.29 (-1.14%)
TSLA   346.11 (-1.09%)
T   39.16 (-0.03%)
AMD   37.52 (+2.21%)
F   8.81 (-2.54%)
ACB   3.55 (-0.56%)
PRI   128.60 (-1.04%)
NFLX   283.11 (-3.05%)
BAC   32.79 (-0.91%)
GILD   63.33 (-1.54%)
DIS   148.72 (+7.32%)
S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
AAPL   264.47 (+1.02%)
FB   193.19 (-0.66%)
MSFT   147.31 (+0.16%)
GOOGL   1,296.18 (-0.08%)
AMZN   1,753.11 (-1.40%)
CGC   18.50 (-3.90%)
NVDA   208.57 (-0.50%)
MU   46.30 (-1.28%)
BABA   182.48 (-2.40%)
GE   11.29 (-1.14%)
TSLA   346.11 (-1.09%)
T   39.16 (-0.03%)
AMD   37.52 (+2.21%)
F   8.81 (-2.54%)
ACB   3.55 (-0.56%)
PRI   128.60 (-1.04%)
NFLX   283.11 (-3.05%)
BAC   32.79 (-0.91%)
GILD   63.33 (-1.54%)
DIS   148.72 (+7.32%)
S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
AAPL   264.47 (+1.02%)
FB   193.19 (-0.66%)
MSFT   147.31 (+0.16%)
GOOGL   1,296.18 (-0.08%)
AMZN   1,753.11 (-1.40%)
CGC   18.50 (-3.90%)
NVDA   208.57 (-0.50%)
MU   46.30 (-1.28%)
BABA   182.48 (-2.40%)
GE   11.29 (-1.14%)
TSLA   346.11 (-1.09%)
T   39.16 (-0.03%)
AMD   37.52 (+2.21%)
F   8.81 (-2.54%)
ACB   3.55 (-0.56%)
PRI   128.60 (-1.04%)
NFLX   283.11 (-3.05%)
BAC   32.79 (-0.91%)
GILD   63.33 (-1.54%)
DIS   148.72 (+7.32%)
Log in

Wright Medical Group Stock Price, Forecast & Analysis (NASDAQ:WMGI)

$29.39
-0.01 (-0.03 %)
(As of 11/13/2019 04:00 PM ET)
Today's Range
$29.35
Now: $29.39
$29.43
50-Day Range
$19.32
MA: $21.98
$29.50
52-Week Range
$19.04
Now: $29.39
$32.86
Volume8.67 million shs
Average Volume2.51 million shs
Market Capitalization$3.72 billion
P/E Ratio327.00
Dividend YieldN/A
Beta0.78
Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells upper and lower extremities, and biologics products in the United States, Europe, the Middle East, Africa, Canada, Asia, Australia, and Latin America. The company offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth. Read More…

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:WMGI
CUSIPN8723710
Phone31-20-521-4777

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$836.19 million
Cash Flow$1.13 per share
Book Value$7.45 per share

Profitability

Net Income$-169,510,000.00

Miscellaneous

Employees2,894
Market Cap$3.72 billion
Next Earnings DateN/A
OptionableOptionable

Receive WMGI News and Ratings via Email

Sign-up to receive the latest news and ratings for WMGI and its competitors with MarketBeat's FREE daily newsletter.


Wright Medical Group (NASDAQ:WMGI) Frequently Asked Questions

What is Wright Medical Group's stock symbol?

Wright Medical Group trades on the NASDAQ under the ticker symbol "WMGI."

How often does Wright Medical Group pay dividends? What is the dividend yield for Wright Medical Group?

Wright Medical Group announced a dividend on Tuesday, December 11th. Investors of record on Wednesday, December 5th will be paid a dividend of $1.50 per share on Monday, December 10th. The ex-dividend date of this dividend is Wednesday, December 12th. View Wright Medical Group's Dividend History.

How were Wright Medical Group's earnings last quarter?

Wright Medical Group NV (NASDAQ:WMGI) released its quarterly earnings results on Wednesday, August, 8th. The medical device company reported ($0.03) EPS for the quarter, beating the Zacks' consensus estimate of ($0.06) by $0.03. The medical device company earned $205.40 million during the quarter, compared to analysts' expectations of $197.20 million. Wright Medical Group had a negative net margin of 14.65% and a positive return on equity of 1.38%. The business's revenue for the quarter was up 14.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.07) EPS. View Wright Medical Group's Earnings History.

What price target have analysts set for WMGI?

13 brokerages have issued 1-year target prices for Wright Medical Group's stock. Their forecasts range from $24.00 to $40.00. On average, they expect Wright Medical Group's share price to reach $30.81 in the next year. This suggests a possible upside of 4.8% from the stock's current price. View Analyst Price Targets for Wright Medical Group.

What is the consensus analysts' recommendation for Wright Medical Group?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Wright Medical Group in the last year. There are currently 9 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Wright Medical Group.

What are Wall Street analysts saying about Wright Medical Group stock?

Here are some recent quotes from research analysts about Wright Medical Group stock:
  • 1. Needham & Company LLC analysts commented, "WMGI’s 4Q18 revenue was consistent with its preannouncement while EBITDA and EPS beat consensus. For 2019, management provided revenue, EBITDA, and EPS guidance that all bracketed consensus. Organic revenue growth slowed to 10.1% (adjusted for selling days) from 14.4% in 3Q18 as strong US Lower Extremities growth was offset by slower US Upper Extremities growth (faced its toughest comp of the year). Given the improving Lower Extremities growth, Augment Injectable launch, and Cartiva acquisition, we have increased confidence that WMGI can exceed consensus in 2019 despite some likely moderation in its US Upper Extremities growth and we reiterate our Buy rating." (2/27/2019)
  • 2. Cantor Fitzgerald analysts commented, "We reiterate our Overweight rating and a 12-month price target of $35 on shares of WMGI. We think WMGI is positioned to outperform expectations in 2018 with multiple drivers across each of its three primary segments (lower extremities, upper extremities, and biologics) to accelerate growth. We see WMGI’s valuation as attractive, as we expect innovative products to help WMGI to capitalize on the evolving market trends. Valuation Summary We base our $35 price target on a ~5.5x EV/Sales multiple on our 2019 sales estimate." (12/10/2018)

Has Wright Medical Group been receiving favorable news coverage?

News headlines about WMGI stock have been trending very negative on Wednesday, according to InfoTrie Sentiment. The research firm identifies negative and positive media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Wright Medical Group earned a news sentiment score of -3.2 on InfoTrie's scale. They also assigned press coverage about the medical device company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the stock's share price in the immediate future. View News Stories for Wright Medical Group.

Are investors shorting Wright Medical Group?

Wright Medical Group saw a increase in short interest in September. As of September 30th, there was short interest totalling 17,170,000 shares, an increase of 12.4% from the August 30th total of 15,270,000 shares. Based on an average trading volume of 2,570,000 shares, the short-interest ratio is currently 6.7 days. Approximately 13.7% of the company's stock are short sold. View Wright Medical Group's Current Options Chain.

Who are some of Wright Medical Group's key competitors?

What other stocks do shareholders of Wright Medical Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Wright Medical Group investors own include Exelixis (EXEL), Gilead Sciences (GILD), Immunomedics (IMMU), The Medicines (MDCO), Vereit (VER), GW Pharmaceuticals PLC- (GWPH), Horizon Therapeutics (HZNP), Intercept Pharmaceuticals (ICPT), PTC Therapeutics (PTCT) and Zoetis (ZTS).

Who are Wright Medical Group's key executives?

Wright Medical Group's management team includes the folowing people:
  • Mr. Robert J. Palmisano, Pres, CEO & Exec. Director (Age 74)
  • Mr. Lance A. Berry, Exec. VP, CFO & COO (Age 47)
  • Mr. Andrew C. Morton, Sr. VP & Chief HR Officer (Age 53)
  • Mr. Kevin D. Cordell, Exec. VP & Chief Global Commercial Officer (Age 53)
  • Mr. Peter S. Cooke, Pres of emerging markets, Australia & Japan (Age 54)

Who are Wright Medical Group's major shareholders?

Wright Medical Group's stock is owned by many different of institutional and retail investors. Top institutional investors include Fisher Asset Management LLC (2.37%), Eagle Asset Management Inc. (1.16%), GW&K Investment Management LLC (1.03%), Chicago Capital LLC (0.69%), Peregrine Capital Management LLC (0.52%) and Gabelli Funds LLC (0.35%). Company insiders that own Wright Medical Group stock include Andrew C Morton, Barry J Regan, David D Stevens, Elizabeth H Weatherman, Gregory Morrison, James Lightman, Jennifer S Walker, John L Miclot, Jonathan Wesley Porter, Julie Andrews, Julie D Dewey, Kevin C Oboyle, Kevin D Cordell, Lance A Berry, Patrick Fisher, Peter Cooke, Richard F Wallman, Robert J Palmisano, Robert P Burrows III and Tim Lanier. View Institutional Ownership Trends for Wright Medical Group.

Which major investors are selling Wright Medical Group stock?

WMGI stock was sold by a variety of institutional investors in the last quarter, including Peregrine Capital Management LLC, First Mercantile Trust Co., Strs Ohio, Eagle Asset Management Inc. and Dupont Capital Management Corp. Company insiders that have sold Wright Medical Group company stock in the last year include Andrew C Morton, David D Stevens, Elizabeth H Weatherman, John L Miclot, Jonathan Wesley Porter, Julie Andrews, Julie D Dewey, Kevin C Oboyle, Kevin D Cordell, Lance A Berry, Patrick Fisher and Tim Lanier. View Insider Buying and Selling for Wright Medical Group.

Which major investors are buying Wright Medical Group stock?

WMGI stock was acquired by a variety of institutional investors in the last quarter, including Public Employees Retirement Association of Colorado, GW&K Investment Management LLC, State of New Jersey Common Pension Fund D, Fisher Asset Management LLC, California Public Employees Retirement System, Mitsubishi UFJ Asset Management UK Ltd., Chicago Capital LLC and SG Americas Securities LLC. Company insiders that have bought Wright Medical Group stock in the last two years include Barry J Regan, Elizabeth H Weatherman, Richard F Wallman and Robert J Palmisano. View Insider Buying and Selling for Wright Medical Group.

How do I buy shares of Wright Medical Group?

Shares of WMGI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Wright Medical Group's stock price today?

One share of WMGI stock can currently be purchased for approximately $29.39.

How big of a company is Wright Medical Group?

Wright Medical Group has a market capitalization of $3.72 billion and generates $836.19 million in revenue each year. Wright Medical Group employs 2,894 workers across the globe.View Additional Information About Wright Medical Group.

What is Wright Medical Group's official website?

The official website for Wright Medical Group is http://www.wright.com/.

How can I contact Wright Medical Group?

Wright Medical Group's mailing address is PRINS BERNHARDPLEIN 200, AMSTERDAM P7, 1097 JB. The medical device company can be reached via phone at 31-20-521-4777 or via email at [email protected]


MarketBeat Community Rating for Wright Medical Group (NASDAQ WMGI)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  532 (Vote Outperform)
Underperform Votes:  506 (Vote Underperform)
Total Votes:  1,038
MarketBeat's community ratings are surveys of what our community members think about Wright Medical Group and other stocks. Vote "Outperform" if you believe WMGI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WMGI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/13/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel